• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB ENVISTA INTRAOCULAR LENS Back to Search Results
Model Number MXUE
Device Problems Material Opacification (1426); Particulates (1451)
Patient Problems Eye Injury (1845); Visual Impairment (2138)
Event Date 04/08/2019
Event Type  Injury  
Manufacturer Narrative
The investigation of this event is in progress.Upon completion of the investigation, a follow-up report will be submitted.
 
Event Description
It was reported that the surgeon noticed what appeared to be central granular opacity in the visual axis below the iol surface, which resulted in an explant of the lens.A lens exchange with the same model and diopter was performed.
 
Manufacturer Narrative
Correction to the reportability awareness date was 14 may 2019.The lens was returned for evaluation.The optic has been cut or torn in half.Microscopic examination found loose particulates on the optic, however, embedded particulates are not present on the optic.Visual inspection found some large and small areas on the optic that are cloudy white in appearance.In addition, there are raised areas that have the appearance of particles or substances that do not wipe off.The microscopy performed did not reveal central granular opacity, as these areas seemed to be concentrated in the outer half of the lens rather than the center.There were a few unspecific deposits of what appeared to be dry ophthalmic viscosurgical device (ovd), as well as a relatively large piece of a dark deposit close to the bisection site.The dark deposit did not appear to be a piece of ocular tissue, but a contaminant which detached from the surface of the lens after hydration in distilled water at body temperature for 24 hours.Attachment of this material to the iol surface may have occurred during manipulation of the lens after explantation.In the dry state or after full hydration no central granular opacity was observed.The investigation of this event is in progress.A follow up report will be submitted upon completion of the investigation.
 
Event Description
The patient did experience a decrease in vision, but the patient's prognosis is excellent and post-op vision was at target with excellent acuity.
 
Manufacturer Narrative
Additional product evaluation was performed.Central granular opacity was not observed.There were no deposits on or within the lens looking like calcification; there were no glistenings or subsurface nanoglistenings.The product evaluation did not confirm the failure mode.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.A root cause for the reported event could not be conclusively determined.Due to evidence of use / handling, the most probable root cause is operational context.No corrective action is necessary at this time.The investigation is complete.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVISTA INTRAOCULAR LENS
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman st
rochester NY 14609
MDR Report Key8693805
MDR Text Key147857416
Report Number0001313525-2019-00095
Device Sequence Number1
Product Code HQL
Combination Product (y/n)Y
PMA/PMN Number
P080021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 01/01/2005,04/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model NumberMXUE
Device Catalogue NumberMXUE2200
Device Lot Number3771709
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/30/2019
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received07/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age65 YR
-
-